Report
Martial Descoutures ...
  • Oussema Denguir

Cosmo Pharmaceuticals : Partnership strategy reaffirmed

>Winlevi/Breezula will be the growth driver in the short term - To coincide with the publication of its annual results, Cosmo organised a CMD to highlight its ambitions, particularly for Winlevi, GI Genius and the next stages in its pipeline. Indeed, the company has strong ambitions, notably its 2025 guidance. After receiving $100m from Medtronic in February, management hopes to receive a further $100m from its partner by the end of the year, which will ensure that i...
Underlying
Cosmo Pharmaceuticals NV

Cosmo Pharmaceuticals N.V. is a specialty pharmaceutical company. The Company develops therapies for gastrointestinal disorders. The Company's clinical development pipeline specifically addresses treatments for inflammatory bowel diseases, colorectal cancer diagnosis and colonoscopy. It has developed a medical device for polyp excision and is developing a product for the detection of colon cancer. Its pipeline includes Lialda/Mezavant/Mesavancol, which is indicated for mild to moderate ulcerative colitis; Uceris/Cortiment, which is indicated for mild to moderate ulcerative colitis; Zacol NMX, which is indicated for intestinal disorders; Rifamycin SV MMX, which is indicated for Travelers' Diarrhea and uncomplicated diverticulitis, among others; CB-17-01, which is indicated for chromoendoscopy for colorectal cancer prevention in surveillance patients; CB-17-04, which is a sub mucosal injectable composition, and CB-01-12, which is an antibody anti-tumor necrosis factor (TNF) alpha drug.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Martial Descoutures

Oussema Denguir

Other Reports on these Companies
Other Reports from Oddo BHF
Anthony Dick ... (+6)
  • Anthony Dick
  • Christophe-Raphaël Ganet
  • Marc Lavaud
  • Olfa Taamallah
  • Usama Tariq
  • Yan Derocles
Anthony Dick ... (+7)
  • Anthony Dick
  • Bruno Cavalier
  • Christophe-Raphaël Ganet
  • Marc Lavaud
  • Olfa Taamallah
  • Usama Tariq
  • Yan Derocles
Anthony Dick ... (+5)
  • Anthony Dick
  • Bruno Cavalier
  • Christophe-Raphaël Ganet
  • Jean Danjou
  • Marc Lavaud

ResearchPool Subscriptions

Get the most out of your insights

Get in touch